Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
190
Bubeník J, Kieler J, Tromholt V, Steven K, Indrová M, Toulcová A.
Activation of killer cells from blood of urinary bladder carcinoma patients by short-term treatment with recombinant interleukin 2Folia Biol (Praha)
1986
32(3):183-94
PubMed ID: 3488923
189
Bubeńik J, Kieler J, Perlmann P, Paulie S, Koho H, Christensen B, Dienstbier Z, Koprivová H, Pospísil J, Poucková P.
Monoclonal antibodies against human urinary bladder carcinomas: selectivity and utilization for gamma scintigraphyEur J Cancer Clin Oncol
1985
21(6):701-10
PubMed ID: 3894033
DOI: 10.1016/0277-5379(85)90267-6
16352
Shimizu R, Ohira T, Yagyu T, Yumioka T, Yamaguchi N, Iwamoto H, Morizane S, Hikita K, Honda M, Takenaka A, Kugoh H.
Activation of PPARγ in bladder cancer via introduction of the long arm of human chromosome 9Oncol Lett
2022
23(3):92
PubMed ID: 35154423
DOI: 10.3892/ol.2022.13212
11877
Nozaki S, Nakatani Y, Mawatari A, Shibata N, Hume WE, Hayashinaka E, Wada Y, Doi H, Watanabe Y.
18F-FIMP: a LAT1-specific PET probe for discrimination between tumor tissue and inflammation.Sci Rep
2019
PubMed ID: 31673030
DOI: 10.1038/s41598-019-52270-x
14444
Kameyama K, Horie K, Mizutani K, Kato T, Fujita Y, Kawakami K, Kojima T, Miyazaki T, Deguchi T, Ito M.
Enzalutamide inhibits proliferation of gemcitabine-resistant bladder cancer cells with increased androgen receptor expressionInt J Oncol
2017
50(1):75-84
PubMed ID: 27909718
DOI: 10.3892/ijo.2016.3781
5877
Yamamoto H, Okumura K, Toshima S, Mukaisho K, Sugihara H, Hattori T, Kato M, Asano S.
FXYD3 protein involved in tumor cell proliferation is overproduced in human breast cancer tissues.Biol Pharm Bull
2009
32(7):1148-54
PubMed ID: 19571376
DOI: 10.1248/bpb.32.1148
13714
Futami K, Kumagai E, Makino H, Goto H, Takagi M, Shimamoto A, Furuichi Y.
Induction of mitotic cell death in cancer cells by small interference RNA suppressing the expression of RecQL1 helicaseCancer Sci
2008
99(1):71-80
PubMed ID: 17953710
DOI: 10.1111/j.1349-7006.2007.00647.x
2531
Masters JR, Thomson JA, Daly-Burns B, Reid YA, Dirks WG, Packer P, Toji LH, Ohno T, Tanabe H, Arlett CF, Kelland LR, Harrison M, Virmani A, Ward TH, Ayres KL, Debenham PG.
Short tandem repeat profiling provides an international reference standard for human cell lines.Proc Natl Acad Sci U S A.
2001
98(14):8012-7
PubMed ID: 11416159
DOI: 10.1073/pnas.121616198
16905
Kawai K, Hayashi H, Ozaki Y, Saijo K, Liu SQ, Akaza H, Ohno T.
Assessment of the number of local cytotoxic T lymphocytes required for degradation of micrometer-size tumor spheroidsCytotechnology
2001
37(1):31-40
PubMed ID: 19002912
DOI: 10.1023/A:1016139010531
3759
Kataoka H, Uchino H, Iwamura T, Seiki M, Nabeshima K, Koono M.
Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity.Am J Pathol
1999
154(2):457-68
PubMed ID: 10027404
DOI: 10.1016/s0002-9440(10)65292-3
5969
Morita M, Yoshiuchi N, Arakawa H, Nishimura S.
CMAP: a novel cystatin-like gene involved in liver metastasis.Cancer Res
1999
59(1):151-8
PubMed ID: 9892200
2181
Ryusuke Futatsuya M.D., Ph.D. Hitomi Kimura M.D. Masatoshi Maeda Ph.D. Miki Shoji Ph.D. Takashi Honda Ph.D.
Assessment of intrinsic radiosensitivity of human bladder cancer cell lines using colorimetric‐MTT and micronucleus assaysRadiation Oncology Investigations
1996
4:249-254
DOI: 10.1002/(SICI)1520-6823
1902
Shu Qin Liu, Kaoru Saijo, Makoto Kodama, Tadao Ohno
Intelligent matrices for tumor-specific cytotoxic T lymphocytesMaterials Science and Engineering: C
1994
2:61-65
DOI: 10.1016/0928-4931(94)90030-2